188 related articles for article (PubMed ID: 37735436)
1. Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers.
Ren F; Jin Q; Liu T; Ren X; Zhan Y
J Transl Med; 2023 Sep; 21(1):646. PubMed ID: 37735436
[TBL] [Abstract][Full Text] [Related]
2. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
3. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis.
Zou M; Shao Z
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773
[TBL] [Abstract][Full Text] [Related]
4. Identification of plasma protein markers of allergic disease risk: a mendelian randomization approach to proteomic analysis.
Cao Z; Li Q; Li Y; Wu J
BMC Genomics; 2024 May; 25(1):503. PubMed ID: 38773393
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
[TBL] [Abstract][Full Text] [Related]
6. Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis.
Su Z; Wan Q
Front Immunol; 2024; 15():1342912. PubMed ID: 38707900
[TBL] [Abstract][Full Text] [Related]
7. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome.
Sun J; Zhao J; Jiang F; Wang L; Xiao Q; Han F; Chen J; Yuan S; Wei J; Larsson SC; Zhang H; Dunlop MG; Farrington SM; Ding K; Theodoratou E; Li X
Genome Med; 2023 Sep; 15(1):75. PubMed ID: 37726845
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
[TBL] [Abstract][Full Text] [Related]
10. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
11. Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: A mendelian randomisation study.
Vithayathil M; Carter P; Kar S; Mason AM; Burgess S; Larsson SC
PLoS Med; 2021 Jul; 18(7):e1003706. PubMed ID: 34324486
[TBL] [Abstract][Full Text] [Related]
12. Causal roles and clinical utility of cardiovascular proteins in colorectal cancer risk: a multi-modal study integrating mendelian randomization, expression profiling, and survival analysis.
Tan C; Li Y; Wang K; Lin Y; Chen Y; Zheng X
BMC Med Genomics; 2024 May; 17(1):138. PubMed ID: 38778378
[TBL] [Abstract][Full Text] [Related]
13. Promising therapeutic targets for ischemic stroke identified from plasma and cerebrospinal fluid proteomes: a multicenter Mendelian randomization study.
Zou X; Wang L; Wang S; Zhang Y; Ma J; Chen L; Li Y; Yao TX; Zhou H; Wu L; Tang Q; Ma S; Zhang X; Tang R; Yi Y; Liu R; Zeng Y; Zhang L
Int J Surg; 2024 Feb; 110(2):766-776. PubMed ID: 38016292
[TBL] [Abstract][Full Text] [Related]
14. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
[TBL] [Abstract][Full Text] [Related]
15. Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers.
Sun J; Luo J; Jiang F; Zhao J; Zhou S; Wang L; Zhang D; Ding Y; Li X
J Natl Cancer Inst; 2024 Apr; 116(4):565-573. PubMed ID: 38039160
[TBL] [Abstract][Full Text] [Related]
16. Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants.
Larsson SC; Carter P; Kar S; Vithayathil M; Mason AM; Michaƫlsson K; Burgess S
PLoS Med; 2020 Jul; 17(7):e1003178. PubMed ID: 32701947
[TBL] [Abstract][Full Text] [Related]
17. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
Lin J; Zhou J; Xu Y
Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the susceptibility to breast cancer: an in-depth proteomic and transcriptomic investigation into novel potential plasma protein biomarkers.
Wang Y; Yi K; Chen B; Zhang B; Jidong G
Front Mol Biosci; 2023; 10():1340917. PubMed ID: 38304232
[No Abstract] [Full Text] [Related]
19. Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study.
Ruan X; Huang D; Zhan Y; Huang J; Huang J; Ng AT; Tsu JH; Na R
Elife; 2023 Nov; 12():. PubMed ID: 37917154
[TBL] [Abstract][Full Text] [Related]
20. Insight into telomere regulation: road to discovery and intervention in plasma drug-protein targets.
Ding K; Zhangwang J; Lei M; Xiong C
BMC Genomics; 2024 Mar; 25(1):231. PubMed ID: 38431573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]